ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 623173 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 623173; 2) Community: the network communities that were significantly associated with the response to NSC 623173; 3) Molecule: the relationships between components within communities and NSC 623173; 4) MDR: the compounds that were significantly associated with the NSC 623173.

NSC Compound Enrichment Correlation
NSC 703784 L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride 0.0434721470609156 -0.17970387
NSC 706992 Null 0.0434721470609156 0.097764977
NSC 726442 4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride 0.0434721470609156 0.18478246
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.0434721470609156 0.29070837
NSC 733149 Null 0.0434721470609156 0.27141783
NSC 752506 5-nitro-N-((pyridin-3-yl)methyl)furan-2-carboxamide 0.0434721470609156 -0.022162365
NSC 92207 Null 0.0434721470609156 0.43409051
NSC 93819 Depakine 0.0434721470609156 0.12744133
NSC 9594 Safranin bluish 0.0434721470609156 0.21836044
NSC 201290 Octadecanamide, N-(1.beta.-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- 0.0446159312763229 0.38223203
Total:125  Current:99    [First] [Prev] [Next] [Last]